Abbott (NYSE:ABT) today said it launched a new bundle with Withings for its Lingo over-the-counter glucose biosensor.
Abbott Laboratories ABT recently made Lingo, its continuous glucose monitoring (CGM) system, available in the United States without a prescription. The system comes with a biosensor and a mobile app ...
Abbott Laboratories ABT recently announced that Lingo, its first over-the-counter biowearable continuous glucose monitor system (CGM), can now be used with Android devices. Previously available only ...
Abbott on Monday announced it has received FDA clearance for two new CGMs that will be available without a prescription. A CGM is a small sensor that pokes through the skin and tracks a person's ...
While the Lingo CGM is designed for general consumers looking to improve their health, the Libre Rio OTC CGM system is intended for adults with type 2 diabetes who do not use insulin. The Food and ...